Skip to content

Home
Therapeutic Areas
Leadership
R&D
- DENKI
- SYK Kinase Inhibitor
Products
News
Contact

Home
Therapeutic Areas
Leadership
R&D
- DENKI
- SYK Kinase Inhibitor
Products
News
Contact

Home
Therapeutic Areas
Leadership
R&D
- DENKI
- SYK Kinase Inhibitor
Products
News
Contact

Home
Therapeutic Areas
Leadership
R&D
- DENKI
- SYK Kinase Inhibitor
Products
News
Contact

page_title_bar

IACTA_Logo_KO-300×98

Home

Therapeutic Areas

Leadership

R&D

DENKI
SYK Kinase Inhibitor

Products

IC 800
IC 265
Other Products

News

Contact

IPAC Pharma

Contact us

Investor Contact
William Pedranti
Chief Administrative Officer

tel: (844) 422-8279
email: wp@iactapharma.com

IACTA Headquarters
Street 1, Metro Office Park, Lot 6, Suite 204
Guaynabo, Puerto Rico 00968

Connect with us

Recent News

IACTA Pharmaceuticals Announces Expansion of Scientific Advisory Board with Two World-Renowned Key Opinion Leaders June 29, 2022
IACTA Pharmaceuticals to Present at Jefferies Healthcare Conference June 1, 2022
IACTA Pharmaceuticals and TALLC Corporation Announce Strategic Collaboration to Utilize Novel SmartCelle Topical Delivery Technology December 17, 2021
CEO Damon Burrows featured on OIS Podcast November 16, 2021

© IACTA Pharmaceuticals, Inc. 2024. All Rights Reserved.

Terms & Conditions
Privacy Policy

© IACTA Pharmaceuticals, Inc. 2024. All Rights Reserved.

Terms & Conditions
Privacy Policy